STXS logo

STXS
Stereotaxis Inc

2,052
Mkt Cap
$197.42M
Volume
63,792.00
52W High
$3.59
52W Low
$1.69
PE Ratio
-8.07
STXS Fundamentals
Price
$2.03
Prev Close
$1.92
Open
$1.93
50D MA
$1.99
Beta
1.14
Avg. Volume
466,378.27
EPS (Annual)
-$0.2519
P/B
14.36
Rev/Employee
$247,152.67
$206.46
Loading...
Loading...
News
all
press releases
STXS Gains on FDA Nod for Synchrony System, Expands Digital Surgery
STXS jumps on FDA clearance of Synchrony system, a 4K platform integrating cath lab tech with cloud connectivity to boost workflow, precision and digital surgery.
Zacks·8d ago
News Placeholder
More News
News Placeholder
Intuitive Surgical Under Pressure in China: Can It Defend Its Position?
ISRG faces rising pricing pressure in China as local rivals gain ground, but its ecosystem, local manufacturing and disciplined pricing aim to defend its position.
Zacks·13d ago
News Placeholder
Stereotaxis Inc. (STXS) Reports Q4 Loss, Lags Revenue Estimates
Stereotaxis (STXS) delivered earnings and revenue surprises of +5.21% and -5.55%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·1mo ago
News Placeholder
Sight Sciences, Inc. (SGHT) Reports Q4 Loss, Beats Revenue Estimates
Sight Sciences (SGHT) delivered earnings and revenue surprises of +44.83% and +0.34%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·1mo ago
News Placeholder
Can Digital Subscriptions Become ISRG's New Revenue Stream in 2026?
Intuitive Surgical's My Intuitive+ may turn paid in 2026, adding a software-driven revenue layer as renewals begin and digital engagement scales.
Zacks·1mo ago
News Placeholder
OrthoPediatrics (KIDS) Reports Q4 Loss, Tops Revenue Estimates
OrthoPediatrics (KIDS) delivered earnings and revenue surprises of +29.73% and +4.05%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·2mo ago
News Placeholder
TransMedics (TMDX) Beats Q4 Earnings and Revenue Estimates
TransMedics (TMDX) delivered earnings and revenue surprises of +40.02% and +3.11%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·2mo ago
News Placeholder
Beta Bionics, Inc. (BBNX) Reports Q4 Loss, Tops Revenue Estimates
Beta Bionics, Inc. (BBNX) delivered earnings and revenue surprises of +28.57% and +0.07%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·2mo ago
News Placeholder
da Vinci 5 Expands Globally: Can ISRG Beat Overseas Cost Hurdles?
ISRG's da Vinci 5 begins international rollout, but pricing sensitivity, budgets, and reimbursement hurdles could slow adoption outside the United States.
Zacks·3mo ago
News Placeholder
Is ISRG's 20% Procedure Growth the New Normal or a Peak?
ISRG posts 20% Q3 procedure growth as da Vinci and Ion volumes accelerate, but investors question if product cycles and timing effects can sustain it.
Zacks·4mo ago
<
1
2
...
>

Latest STXS News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.